FindTrial
Sign In

SARS-CoV-2 infection in neurocritical care patients during the first and second peak

Clinical and epidemiological profile of the SARS-CoV-2 patients during the first and second peak-an audit in a tertiary neurocritical care unit in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036348
Enrollment
50
Registered
2021-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B342- Coronavirus infection, unspecified Health Condition 2: G00-G99- Diseases of the nervous system

Interventions

Control Intervention1: NIL: This is an observational study

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients more than 18 years with neurological illness and positive for SARS CoV 2 infection

Exclusion criteria

Exclusion criteria: Patients less than 18 years and also those who do not have SARS CoV-2 infection

Design outcomes

Primary

MeasureTime frame
Clinical and epidemiological profile of SARS CoV-2 positive patients with neurological diseasesTimepoint: Two peaks of SARS CoV-2 pandemic—

Secondary

MeasureTime frame
ICU mortalityTimepoint: Two peaks of the SARS CoV-2 pandemic—

Countries

India

Contacts

Public ContactSuparna Bharadwaj

National Institute of Mental Health and Neurosciences

acharya.suparna@gmail.com9483458514

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026